ABSTRACT
In this study, we explore the innovative application of biological principles of scattering foams and structural colouration of white materials to manipulate the transmission properties of thermal infrared (IR) radiation, particularly within the 8-14 µm wavelength range in polyolefin materials. Inspired by the complex skin of organisms such as chameleons, which can dynamically change colour through structural alterations, as well as more mundane technologies such as Buddha Boards and magic water colouring books, we are developing methods to control thermal IR transmission using common thermoplastic materials that are semi-transparent to thermal IR radiation. Polyethylene and polypropylene, known for their versatility and cost-effectiveness, can be engineered into microstructured sheets with feature sizes spanning from 5 to 100 µm. By integrating these precisely moulded microstructures with index-matching fluids, specifically IR transparent oils, we achieve a reversible modification of the thermal transmission properties. This novel approach not only mimics the adaptive functionality of natural systems but also offers a practical and scalable solution for dynamic thermal management. Our results indicate a promising pathway for the development of new materials that can adapt their IR properties in real time, paving the way for smarter thermal management solutions via radiative emission/absorption.
ABSTRACT
We present in this work new methodologies to produce, refine, and interconnect room-temperature liquid-metal-core thermoplastic elastomer wires that have extreme extendibility (>500%), low production time and cost at scale, and may be integrated into commonly used electrical prototyping connectors like a Japan Solderless Terminal (JST) or Dupont connectors. Rather than focus on the development of a specific device, the aim of this work is to demonstrate strategies and processes necessary to achieve scalable production of liquid-metal-enabled electronics and address several key challenges that have been present in liquid metal systems, including leak-free operation, minimal gallium corrosion of other electrode materials, low liquid metal consumption, and high production rates. The ultimate goal is to create liquid-metal-enabled rapid prototyping technologies, similar to what can be achieved with Arduino projects, where modification and switching of components can be performed in seconds, which enables faster iterations of designs. Our process is focused primarily on fibre-based liquid metal wires contained within thermoplastic elastomers. These fibre form factors can easily be integrated with wearable sensors and actuators as they can be sewn or woven into fabrics, or cast within soft robotic components.
ABSTRACT
Objectives: The present study was designed to conduct a comprehensive systematic review and meta-analysis to assess the efficacy of herbal medicines as add-on therapy on lung function in asthmatic patients. Methods: A comprehensive search of online databases was performed up to December 2021 to identify randomized controlled trials that used orally herbal preparations for asthma as add-on therapy. Studies were assessed for methodological quality using the Cochrane Collaboration's Risk of Bias tool. The main outcome was percent predicted value of forced expiratory volume (% predicted FEV1). Pooled weighted mean difference (WMD) estimate with corresponding 95% confidence interval (CI) was calculated using inverse-variance weights method while random effects meta-analysis was used, taking into account clinical and conceptual heterogeneity. Results: As a result, 1,525 studies were identified. 169 studies were reviewed in-depth and 23 studies met our systematic review inclusion criteria. Finally, nine randomized controlled trials were included in the meta-analysis. Findings indicated that use of herbal medicines in patients with asthma significantly improved % predicted FEV1 (WMD 3.73, 95% CI 1.76-5.70), with no evidence for significant heterogeneity (p = 0.56 [Q statistic], I2 = 0.0%). In subgroup analysis by age, improvement in % predicted FEV1 was higher and significant in adults (WMD 5.16; 95% CI 2.68-7.63) compared to children (WMD = 1.27; 95% CI -1.98-4.51). Sensitivity analysis showed the significant effect of herbal medicine consumption on improving FEV1 was consistently (range of summary WMDs 3.27-4.59), indicating that the meta-analysis model was robust. There was no evidence of publication bias both visually and statistically. Conclusion: Findings support, the complementary use of herbal medicines resulted in significant improvement in the lung function compared to standard treatment in asthmatic patients with no considerable adverse events. This improvement is more likely to be observed amongst adults.
ABSTRACT
Objectives: Asthma is a chronic disease, and the demand for herbal medicines in this field has increased in recent years. The new findings highlight the role of the gut-lung axis in the pathophysiology of asthma. Hence, this study will evaluate the safety and efficacy of Glasthma syrup, an herbal formula based on Persian medicine, in improving asthma and regulating intestinal permeability. The formula consists of five herbal ingredients that have anti-inflammatory effects on the respiratory tract, also known as gut tonics. Methods: The study will be conducted as a placebo-controlled, triple-blind, randomized trial. It will consist of a 4-week intervention followed by a 4-week follow-up period. The target sample size is 20 patients with moderate asthma aged 18 to 60 years. Eligible participants will be randomly assigned to either the experimental group or the control group in equal numbers. Patients in the experimental group will take Glasthma syrup (7.5 mL, twice a day), while patients in the control group will take a matching placebo. Both groups will receive a 4-week combination of a long-acting beta2 agonist and a leukotriene modulator as standard of care. Inhaled corticosteroids can be used as rescue medication as needed. Results: The primary outcomes are asthma symptom scale, lung function, and intestinal permeability. Secondary outcomes include quality of life, symptom recurrence rates, and blood tests. A safety assessment will also be conducted during the trial. Conclusion: In this trial, the effects of Glasthma syrup in patients with moderate asthma will be examined. The study will also assess the effects of the formulation on the gut-lung axis by simultaneously monitoring the gut permeability index, asthma symptoms, and lung function.